Blood Clot Retrieval Devices Market Size, Share & Trends Analysis Report By Type (Guidewires, Aspiration devices, Stent retrievers, Others), By Application (Coronary Arteries, Peripheral Arteries, Cerebral Arteries), By End User (Hospitals and Clinics, Ambulatory Surgery Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Blood Clot Retrieval Devices Market Insights

The global blood clot retrieval devices market size was valued at USD 2.18 billion in 2025 and is projected to grow from USD 2.41 billion in 2026 to USD 5.32 billion by 2034, registering a CAGR of 10.43% during the forecast period from 2026 to 2034. North America dominated the blood clot retrieval devices market with a market share of 39.2% in 2025.

Blood clot retrieval devices are advanced medical instruments designed to remove blood clots from blood vessels during procedures aimed at treating conditions like deep vein thrombosis (DVT), pulmonary embolism, or stroke. These devices work by physically extracting or breaking down the clot obstructing the blood vessel, helping to restore normal circulation and preventing further damage to organs and tissues.

The global market is experiencing robust growth, fueled by significant advancements in minimally invasive thrombectomy procedures. Innovations such as stent retrievers, aspiration catheters, and AI-enhanced imaging technologies have significantly improved the efficiency of clot removal, reduced procedural risks, and minimized patient recovery times. These developments are driving the adoption of these devices across various healthcare settings.

The integration of cutting-edge technologies like robotic-assisted thrombectomy, real-time AI analytics, and next-generation aspiration systems is enhancing procedural precision, enabling faster treatment timelines, and increasing success rates. These innovations are particularly transforming stroke care by making clot retrieval procedures safer and more effective, ultimately leading to improved patient outcomes.

Segmentation Analysis

The global blood clot retrieval devices market is segmented into type, application, and end-user.

By Type

Stent retrievers dominate the global market due to their high success rates in mechanical thrombectomy, faster recanalization, and superior patient outcomes. These devices mechanically engage and remove clots, restoring blood flow in ischemic stroke patients. Their widespread adoption is driven by technological advancements, growing stroke incidence, and increasing preference for minimally invasive procedures. Moreover, favorable clinical guidelines and expanding stroke care infrastructure continue to support the segment’s growth.

Request Customizationto receive a tailored report.

By Application

The cerebral arteries segment holds the largest share in the global market, primarily due to the high prevalence of ischemic strokes, which account for the majority of global stroke cases. When a clot obstructs a major brain artery, rapid intervention is crucial to prevent severe disability or death. The growing adoption of mechanical thrombectomy as a frontline treatment, increased awareness of stroke management, and expanding healthcare infrastructure are further fueling demand for cerebral artery interventions.

By End User

Hospitals remain the largest end-user segment in the global market, owing to their specialized stroke care units, access to skilled healthcare professionals, and high patient inflow for thrombectomy procedures. Equipped with advanced imaging technologies, neurovascular intervention units, and emergency stroke response teams, hospitals play a crucial role in treating stroke patients. The increasing adoption of mechanical thrombectomy in hospital settings, alongside supportive reimbursement policies, government funding, and infrastructure expansion, continues to drive market growth.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America: Dominant Region with 41.5% Market Share

North America holds the largest share in the global blood clot retrieval devices market, driven by the high prevalence of ischemic strokes, rapid adoption of innovative thrombectomy technologies, and advanced healthcare infrastructure. The region benefits from favorable reimbursement policies, strong government support for stroke treatment, and a well-established network of stroke centers.

Moreover, leading market players such as Medtronic, Stryker, and Penumbra continue to invest in research and development, introducing next-generation thrombectomy devices. The rising geriatric population, increasing awareness of stroke management, and growing adoption of AI-assisted clot retrieval technologies further strengthen the market’s growth.

Canada's market for blood clot retrieval devices is growing due to the rising prevalence of ischemic strokes, increasing mechanical thrombectomy adoption, and strong government initiatives. The expansion of specialized stroke centers and favorable reimbursement policies enhance access to advanced treatments. Additionally, advancements in AI-driven imaging and robotic-assisted thrombectomy are further accelerating market growth, ensuring more precise and efficient clot retrieval procedures to improve patient outcomes.

The U.S. dominates the blood clot retrieval devices industry due to high investments in R&D, rapid technological advancements, and frequent product launches. The presence of major players like Medtronic, Stryker, and Penumbra drives innovation. In June 2024, MicroVention, Inc., a subsidiary of Terumo Corporation, launched the ERIC retrieval device, enhancing thrombus control, reducing procedure time, and offering versatile thrombectomy options. Strong reimbursement policies and a well-established stroke care infrastructure further boost market growth.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific: Fastest Growing Region with the Highest Market Cagr

Asia-Pacific is projected to register the fastest CAGR, driven by the rising incidence of ischemic strokes, increasing healthcare expenditure, and growing adoption of minimally invasive thrombectomy procedures. Supportive government initiatives, expanding healthcare infrastructure, and rising investments in neurovascular care are fueling market expansion. The region is also experiencing greater accessibility to advanced stroke treatment technologies, collaborations with global medical device manufacturers, and an increasing number of specialized stroke centers, further accelerating market growth.

• India – India’s blood clot retrieval devices market is expanding due to a rising stroke burden, increasing awareness, and supportive government initiatives. In March 2022, Medtronic plc launched India’s first dedicated registry to collect real-world data on revascularization device use in acute ischemic stroke patients. This initiative is helping enhance clinical insights, improve treatment strategies, and boost the adoption of advanced thrombectomy technologies, positioning India as a fast-growing market.
• China– China’s market growth is fueled by a rising incidence of ischemic strokes, increasing healthcare investments, and expanding neurovascular treatment centers. Government-led stroke care initiatives and collaborations with domestic and global medical device manufacturers are strengthening the market. The growing adoption of minimally invasive thrombectomy procedures and AI-assisted stroke management further drives demand, positioning China as a key player in the Asia-Pacific region’s thrombectomy market expansion.
• Japan - Japan is witnessing substantial growth in the market due to high R&D investments, technological advancements, and favorable regulatory policies. In 2024, Inari Medical, Inc. received national reimbursement approval from Japan’s Ministry of Health, Labor, and Welfare (MHLW) for its ClotTriever Thrombectomy System for DVT, underscoring Japan’s commitment to enhancing stroke care and expanding access to next-generation thrombectomy devices.

Company Market Share

Key players in the global blood clot retrieval devices market are actively adopting strategic business approaches to enhance their market position. These strategies include mergers and acquisitions, product innovations, regulatory approvals, geographical expansions, and partnerships with healthcare institutions. Companies are also investing heavily in R&D to develop next-generation thrombectomy devices with improved safety and efficiency.

Penumbra, Inc.: An Emerging Player in the Global Market

Penumbra, Inc. is a leading provider of blood clot retrieval devices, specializing in aspiration-based thrombectomy technologies for treating ischemic stroke, deep vein thrombosis (DVT), and arterial thrombosis. The company’s Lightning Intelligent Aspiration and Indigo systems utilize AI-driven clot detection and real-time feedback to enhance procedural precision and improve patient outcomes.

List of Key and Emerging Players in Blood Clot Retrieval Devices Market